author_facet Farag, Sherif
Ruppert, Amy
Mrózek, Krzysztof
Carroll, Andrew
Pettenati, Mark
Le Beau, Michelle
Peterson, Bercedis
Powell, Bayard
Ozer, Howard
Silver, Richard
Larson, Richard
Bloomfield, Clara
Farag, Sherif
Ruppert, Amy
Mrózek, Krzysztof
Carroll, Andrew
Pettenati, Mark
Le Beau, Michelle
Peterson, Bercedis
Powell, Bayard
Ozer, Howard
Silver, Richard
Larson, Richard
Bloomfield, Clara
author Farag, Sherif
Ruppert, Amy
Mrózek, Krzysztof
Carroll, Andrew
Pettenati, Mark
Le Beau, Michelle
Peterson, Bercedis
Powell, Bayard
Ozer, Howard
Silver, Richard
Larson, Richard
Bloomfield, Clara
spellingShingle Farag, Sherif
Ruppert, Amy
Mrózek, Krzysztof
Carroll, Andrew
Pettenati, Mark
Le Beau, Michelle
Peterson, Bercedis
Powell, Bayard
Ozer, Howard
Silver, Richard
Larson, Richard
Bloomfield, Clara
International Journal of Oncology
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
Cancer Research
Oncology
author_sort farag, sherif
spelling Farag, Sherif Ruppert, Amy Mrózek, Krzysztof Carroll, Andrew Pettenati, Mark Le Beau, Michelle Peterson, Bercedis Powell, Bayard Ozer, Howard Silver, Richard Larson, Richard Bloomfield, Clara 1019-6439 1791-2423 Spandidos Publications Cancer Research Oncology http://dx.doi.org/10.3892/ijo.25.1.143 Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study International Journal of Oncology
doi_str_mv 10.3892/ijo.25.1.143
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzg5Mi9pam8uMjUuMS4xNDM
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzg5Mi9pam8uMjUuMS4xNDM
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint Spandidos Publications, 2004
imprint_str_mv Spandidos Publications, 2004
issn 1019-6439
1791-2423
issn_str_mv 1019-6439
1791-2423
language Undetermined
mega_collection Spandidos Publications (CrossRef)
match_str farag2004prognosticsignificanceofadditionalcytogeneticabnormalitiesinnewlydiagnosedpatientswithphiladelphiachromosomepositivechronicmyelogenousleukemiatreatedwithinterferonaacancerandleukemiagroupbstudy
publishDateSort 2004
publisher Spandidos Publications
recordtype ai
record_format ai
series International Journal of Oncology
source_id 49
title Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
title_unstemmed Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
title_full Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
title_fullStr Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
title_full_unstemmed Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
title_short Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
title_sort prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: a cancer and leukemia group b study
topic Cancer Research
Oncology
url http://dx.doi.org/10.3892/ijo.25.1.143
publishDate 2004
physical
description
container_start_page 0
container_title International Journal of Oncology
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792331647564120067
geogr_code not assigned
last_indexed 2024-03-01T13:44:17.44Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Prognostic+significance+of+additional+cytogenetic+abnormalities+in+newly+diagnosed+patients+with+Philadelphia+chromosome-positive+chronic+myelogenous+leukemia+treated+with+interferon-%CE%B1%3A+A+Cancer+and+Leukemia+Group+B+study&rft.date=2004-07-01&genre=article&issn=1791-2423&jtitle=International+Journal+of+Oncology&atitle=Prognostic+significance+of+additional+cytogenetic+abnormalities+in+newly+diagnosed+patients+with+Philadelphia+chromosome-positive+chronic+myelogenous+leukemia+treated+with+interferon-%CE%B1%3A+A+Cancer+and+Leukemia+Group+B+study&aulast=Bloomfield&aufirst=Clara&rft_id=info%3Adoi%2F10.3892%2Fijo.25.1.143&rft.language%5B0%5D=und
SOLR
_version_ 1792331647564120067
author Farag, Sherif, Ruppert, Amy, Mrózek, Krzysztof, Carroll, Andrew, Pettenati, Mark, Le Beau, Michelle, Peterson, Bercedis, Powell, Bayard, Ozer, Howard, Silver, Richard, Larson, Richard, Bloomfield, Clara
author_facet Farag, Sherif, Ruppert, Amy, Mrózek, Krzysztof, Carroll, Andrew, Pettenati, Mark, Le Beau, Michelle, Peterson, Bercedis, Powell, Bayard, Ozer, Howard, Silver, Richard, Larson, Richard, Bloomfield, Clara, Farag, Sherif, Ruppert, Amy, Mrózek, Krzysztof, Carroll, Andrew, Pettenati, Mark, Le Beau, Michelle, Peterson, Bercedis, Powell, Bayard, Ozer, Howard, Silver, Richard, Larson, Richard, Bloomfield, Clara
author_sort farag, sherif
container_start_page 0
container_title International Journal of Oncology
description
doi_str_mv 10.3892/ijo.25.1.143
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzg5Mi9pam8uMjUuMS4xNDM
imprint Spandidos Publications, 2004
imprint_str_mv Spandidos Publications, 2004
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 1019-6439, 1791-2423
issn_str_mv 1019-6439, 1791-2423
language Undetermined
last_indexed 2024-03-01T13:44:17.44Z
match_str farag2004prognosticsignificanceofadditionalcytogeneticabnormalitiesinnewlydiagnosedpatientswithphiladelphiachromosomepositivechronicmyelogenousleukemiatreatedwithinterferonaacancerandleukemiagroupbstudy
mega_collection Spandidos Publications (CrossRef)
physical
publishDate 2004
publishDateSort 2004
publisher Spandidos Publications
record_format ai
recordtype ai
series International Journal of Oncology
source_id 49
spelling Farag, Sherif Ruppert, Amy Mrózek, Krzysztof Carroll, Andrew Pettenati, Mark Le Beau, Michelle Peterson, Bercedis Powell, Bayard Ozer, Howard Silver, Richard Larson, Richard Bloomfield, Clara 1019-6439 1791-2423 Spandidos Publications Cancer Research Oncology http://dx.doi.org/10.3892/ijo.25.1.143 Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study International Journal of Oncology
spellingShingle Farag, Sherif, Ruppert, Amy, Mrózek, Krzysztof, Carroll, Andrew, Pettenati, Mark, Le Beau, Michelle, Peterson, Bercedis, Powell, Bayard, Ozer, Howard, Silver, Richard, Larson, Richard, Bloomfield, Clara, International Journal of Oncology, Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study, Cancer Research, Oncology
title Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
title_full Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
title_fullStr Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
title_full_unstemmed Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
title_short Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
title_sort prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: a cancer and leukemia group b study
title_unstemmed Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A Cancer and Leukemia Group B study
topic Cancer Research, Oncology
url http://dx.doi.org/10.3892/ijo.25.1.143